Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy for High Risk Childhood ALL (LAL-AR-N-2005)
NCT00526409Phase 4Completed
- Sponsor
- Fundación PETHEMA
- Start
- Jun 2005
- Primary completion
- Oct 2014
- Modality
- Monoclonal Antibodies, Lipid-based Nanoparticles, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisolone, daunorubicin, vincristine sulfate liposome injection, asparaginase escherichia coli, cyclophosphamide in acute lymphoblastic leukemia (ALL), sponsored by Fundación PETHEMA. Started Jun 2005; status: completed.
02
Drugs
prednisolonedaunorubicinvincristine sulfate liposome injectionasparaginase escherichia colicyclophosphamide
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00526409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526409.